Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

BIOTOOL-CHF BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure

Coordinator
Irccs Azienda Ospedaliero- Universitaria Di Bologna, Italy
Runs
1 October 2023 to 30 September 2028
Status
Running
EU funding
€9.6m
Total cost
€9.6m
Partners
25 organisations in 11 countries
Type
Research and Innovation Action
Grant agreement
101095653

What the project is doing

In the project's own words, from its summary on CORDIS.

Heart failure (HF) is a chronic clinical condition involving up to 6.5 million people in Europe, the most frequent cause of hospitalization in adults with a 5-year mortality rate up to 70%. Several drugs positively modify the course of disease in the patients with HF with reduced ejection fraction (HFrEF), with a high level of evidence. Besides, the use of diuretics, the basic cornerstone of symptoms relief in HFrEF by targeting congestion, is supported by poor and outdated evidence.

Congestion drives symptoms worsening leading to hospital admission. Clinical evaluation of congestion is often inaccurate and insensitive to detect interstitial or intravascular fluid overload, and thus insufficient to guide use of diuretics. Indeed, their use is inefficient, with studies showing that up to 70% of patients with chronic HFrEF show congestion despite diuretic therapy, the use of diuretics does prevent clinical events in patients discharged after an acute heart failure episode, and diuretics may represent a barrier to adherence to disease modifier therapies.

An appropriate management of diuretic therapy is therefore crucial to overcome the risk of re-hospitalisation, manage patients symptoms, and achieve target guideline-directed medical therapy. To fill these gaps, BIOTOOL-CHF will 1) validate a set of qualified biomarkers estimating congestion, 2) define a multiparametric artificial intelligence-based score predicting congestion and prognosis, 3) develop a decision-making tool to manage congestion by diuretics, 4) develop a Point of Care companion diagnostic (CD) to assess biomarkers concentrations 5) set up a Strategy plan for industrial development and market access of the CD.

This approach will support the definition of a framework to regulatory agencies and scientific societies to disseminate recommendations for a more efficient use of existing pharmaceuticals and allow a personalised strategy for the management of HFrEF, by using new tools and digital solutions.

Topics

Who is involved

OrganisationCityCountryRole
Irccs Azienda Ospedaliero- Universitaria Di BolognaBolognaItalyCoordinator
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Fachhochschule Nordwestschweiz FhnwWindischSwitzerlandAssociatedpartner
Universitaet Zu LuebeckLubeckGermanyThird party
Universitatsklinikum Schleswig-HolsteinLübeckGermanyParticipant
Region HovedstadenHillerodDenmarkParticipant
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceParticipant
Onaseio Kardiocheirourgiko KentroAthinaGreeceParticipant
Fundacion Para La Investigacion Del Hospital Clinico De La Comunitat Valenciana, Fundacion InclivaValenciaSpainParticipant
Institut De Investigacio En Ciencies De La Salut Germans Trias I PujolBadalona BarcelonaSpainParticipant
Assistance Publique Hopitaux De ParisParisFranceParticipant
Ecrin European Clinical Research Infrastructure NetworkParisFranceParticipant
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant
Predict4healthParisFranceParticipant
Alma Mater Studiorum - Universita Di BolognaBolognaItalyParticipant
Associazione Italiana Scompensati Cardiaci Associazione Di Promozione SocialeRomaItalyParticipant
Hcf Fondazione Anmco per Il Tuo Cuore EtsFirenzeItalyParticipant
I.m.a. Industria Macchine Automatiche SpAOzzano Dell'EmiliaItalyParticipant
Istituto Superiore Di SanitaRomaItalyThird party
Tinexta Innovation Hub S.p.a.Correggio ReItalyParticipant
Universita Degli Studi Di BresciaBresciaItalyParticipant
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Erasmus Universiteit RotterdamRotterdamNetherlandsParticipant
Region StockholmStockholmSwedenParticipant
Univerzitetni Klinicni Center LjubljanaLjubljanaSloveniaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI